Role of microRNA-29b in angiotensin II-induced epithelial-mesenchymal transition in renal tubular epithelial cells

International Journal of Molecular Medicine

Volumn 34, Issue 5, 2014, Pages 1381-1387

  Pan, Jialin ^c   Zhang, Juhong ^a   Zhang, Xingwei ^a   Zhou, Xi ^b   Lu, Shengyue ^b   Huang, Xiaoyan ^a   Shao, Jiayu ^b   Lou, Guoqiang ^a   Yang, Deye ^a,b   Geng, Yong Jian ^d  

^a HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^c THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Angiotensin II; Epithelial mesenchymal transition; MicroRNA 29b; NRK 52E cells; Spontaneously hypertensive rats

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; COLLAGEN TYPE 1; MICRORNA 29B; TRANSFORMING GROWTH FACTOR BETA; TRIPHENYLTETRAZOLIUM; ACTIN; MICRORNA; MIRN29 MICRORNA, RAT; SMOOTH MUSCLE ACTIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENETIC TRANSFECTION; IN VITRO STUDY; KIDNEY CORTEX; KIDNEY EPITHELIUM; MALE; NONHUMAN; PROTEIN FUNCTION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; UPREGULATION; ANIMAL; CELL LINE; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; GENETICS; KIDNEY TUBULE; METABOLISM; WISTAR KYOTO RAT;

ACTINS; ANGIOTENSIN II; ANIMALS; CELL LINE; COLLAGEN TYPE I; DOWN-REGULATION; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; KIDNEY TUBULES; MICRORNAS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 84907218383     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1935     Document Type: Article

References (31)

1. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A and Bozzoni I: A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147: 358-369, 2011.
2. Choi YJ, Lin CP, Ho JJ, He X, Okada N, Bu P, Zhong Y, Kim SY, Bennett MJ, Chen C, Ozturk A, Hicks GG, Hannon GJ and He L: miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol 13: 1353-1360, 2011.
3. Wang G, Kwan BC, Lai FM, Chow KM, Li PK and Szeto CC: Urinary miR-21, miR-29, and miR-93: novel biomarkers of fibrosis. Am J Nephrol 36: 412-418, 2012.
4. Lekgabe ED, Kiriazis H, Zhao C, Xu Q, Moore XL, Su Y, Bathgate RA, Du XJ and Samuel CS: Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats. Hypertension 46: 412-418, 2005.
5. Cheng HF, Wang JL, Vinson GP and Harris RC: Young SHR express increased type 1 angiotensin II receptors in renal proximal tubule. Am J Physiol 274: F10-F17, 1998.
6. Matsushima Y, Kawamura M, Akabane S, Imanishi M, Kuramochi M, Ito K and Omae T: Increases in renal angiotensin II content and tubular angiotensin II receptors in prehypertensive spontaneously hypertensive rats. J Hypertens 6: 791-796, 1988.
7. Mezzano SA, Ruiz-Ortega M and Egido J: Angiotensin II and renal fibrosis. Hypertension 38: 635-638, 2001.
8. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-CT Method. Methods 25: 402-408, 2001.
9. Jimenez E, Perez de la Blanca E, Urso L, Gonzalez I, Salas J and Montiel M: Angiotensin II induces MMP 2 activity via FAK/JNK pathway in human endothelial cells. Biochem Biophys Res Commun 380: 769-774, 2009.
10. Lavoz C, Rodrigues-Diez R, Benito-Martin A, Rayego-Mateos S, Rodrigues-Diez RR, Alique M, Ortiz A, Mezzano S, Egido J and Ruiz-Ortega M: Angiotensin II contributes to renal fibrosis independently of Notch pathway activation. PLoS One 7: e40490, 2012.
11. Pons M, Cousins SW, Alcazar O, Striker GE and Marin-Castano ME: Angiotensin II-induced MMP-2 activity and MMP-14 and basigin protein expression are mediated via the angiotensin II receptor type 1-mitogen-activated protein kinase 1 pathway in retinal pigment epithelium: implications for age-related macular degeneration. Am J Pathol 178: 2665-2681, 2011.
12. Zhong J, Guo D, Chen CB, Wang W, Schuster M, Loibner H, Penninger JM, Scholey JW, Kassiri Z and Oudit GY: Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2. Hypertension 57: 314-322, 2011.
13. Cushing L, Kuang PP, Qian J, Shao F, Wu J, Little F, Thannickal VJ, Cardoso WV and Lu J: miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol 45: 287-294, 2011.
14. Qin W, Chung AC, Huang XR, Meng XM, Hui DS, Yu CM, Sung JJ and Lan HY: TGF-ß/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol 22: 1462-1474, 2011.
15. Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, Schmidt S, Janssen J, Koppe C, Knolle P, Castoldi M, Tacke F, Trautwein C and Luedde T: Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53: 209-218, 2011.
16. Liu GX, Li YQ, Huang XR, Wei L, Chen HY, Shi YJ, Heuchel RL and Lan HY: Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-ß/Smad3-NF.κB-dependent mechanisms in mice. PLoS One 8: e53573, 2013.
17. Han Y, Runge MS and Brasier AR: Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-κB transcription factors. Circ Res 84: 695-703, 1999.
18. Kranzhofer R, Schmidt J, Pfeiffer CA, Hagl S, Libby P and Kubler W: Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19: 1623-1629, 1999.
19. Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J, Cheng A, Hall BM, Qualman SJ, Chandler DS, Croce CM and Guttridge DC: NF-κB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 14: 369-381, 2008.
20. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A and Mendell JT: Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40: 43-50, 2008.
21. Mott JL, Kurita S, Cazanave SC, Bronk SF, Wemeburg NW and Femandez-Zapico ME: Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB. J Cell Biochem 110: 1155-1164, 2010.
22. Sadoshima J and Izumo S: Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro. Roles of phospholipid-derived second messengers. Circ Res 73: 424-438, 1993.
23. Kopp JB: TGF-ß signaling and the renal tubular epithelial cell: too much, too little, and just right. J Am Soc Nephrol 21: 1241-1243, 2010.
24. Meng XM, Huang XR, Chung AC, Qin W, Shao X, Igarashi P, Ju W, Bottinger EP and Lan HY: Smad2 protects against TGF-ß/Smad3-mediated renal fibrosis. J Am Soc Nephrol 21: 1477-1487, 2010.
25. Chung AC, Yu X and Lan HY: MicroRNA and nephropathy: emerging concepts. Int J Nephrol Renovasc Dis 6: 169-179, 2013.
26. Patel V and Noureddine L: MicroRNAs and fibrosis. Curr Opin Nephrol Hypertens 21: 410-416, 2012.
27. Fort A, Borel C, Migliavacca E, Antonarakis SE, Fish RJ and Neerman-Arbez M: Regulation of fibrinogen production by microRNAs. Blood 116: 2608-2615, 2010.
28. Villarreal G Jr, Oh DJ, Kang MH and Rhee DJ: Coordinated regulation of extracellular matrix synthesis by the microRNA-29 family in the trabecular meshwork. Invest Ophthalmol Vis Sci 52: 3391-3397, 2011.
29. Kapinas K, Kessler CB and Delany AM: miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling. J Cell Biochem 108: 216-224, 2009.
30. Inoki K, Haneda M, Ishida T, Mori H, Maeda S, Koya D, Sugimoto T and Kikkawa R: Role of mitogen-activated protein kinases as downstream effectors of transforming growth factor-beta in mesangial cells. Kidney Int Suppl 77: S76-S80, 2000.
31. Luna C, Li G, Qiu J Epstein DL and Gonzalez P: Cross-talk between miR-29 and transforming growth factor-betas in trabecular meshwork cells. Invest Ophthalmol Vis Sci 52: 3567-3572, 2011.